The Use of FLOSEAL to Reduce Bleeding in Total Knee Replacement Surgery
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the agent, Floseal, can decrease the amount of
blood patients lose after total knee replacement (TKR) surgery. If this product can be found
to have an effect on bleeding, it may potentially reduce the problems associated with
bleeding after knee replacement surgery such as pain, stiffness, and the need to have a blood
transfusion. The subject's overall participation will be over a period of 6 weeks.